chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Joint pain, hips; Chills; Diarrhea - feels like hot fire water coming out, to the point my skin is raw around my anus; Diarrhea - feels like hot fire water coming out, to the point my skin is raw around my anus; Joint pain, hips; Chills; Diarrhea - feels like hot fire water coming out, to the point my skin is raw around my anus; Diarrhea - feels like hot fire water coming out, to the point my skin is raw around my anus; This is a spontaneous report from a contactable healthcare professional (patient). A 65-years-old (non-pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number: ER8727), dose 1 via an unspecified route of administration on 22Mar2021 at 15:00 (at the age of 65-years-old) as dose 1, single and dose 2 via an unspecified route of administration on 12Apr2021 (at the age of 65-years-old) (Batch/Lot Number: ER8729) as dose 2, single for COVID-19 immunisation. Medical history included atrial fibrillation (AFib), blood pressure, known allergies includes, penicillin allergy and allergy to sulfur drugs from unspecified dates. Concomitant medications/other medications the patient received within 2 weeks of vaccination included menthol, thymol (SOTOL), rivaroxaban (XARELTO), trazodone, sertraline and valsartan all taken for unspecified indication, start and stop dates were not reported (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in 2021, after the first dose, the patient experienced joint pain, hips, chills, diarrhea - felt like hot fire water coming out to the point her skin was raw around anus. On 15Apr2021 at 12:00, the patient experienced joint pain, hips, chills, diarrhea - felt like hot fire water coming out to the point her skin was raw around anus. It was reported that the patient didn't put two and two together until the today (the day of reporting). The patient reported stating the very same thing happened after first vaccine (on an unspecified date in 2021). The patient thought it was a bug. This lasted 24 hours before. Trying to stay hydrated. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events joint pain, hips, chills and diarrhea - feels like hot fire water coming out, to the point my skin is raw around my anus had recovered on unspecified date (lasted 24 hours); events occurred on 15Apr2021 at 12:00 was reported as recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Pain in the right outer arm, not joint. Painful to open objects, make a fist, lift small items. No change as of 9/10/11. Pain (7 of 10) appears to be muscle related or tendons. A doctor diagnosed recently as tennis elbow, despite no exertion to cause it.
Patient presented 12 days after injection with a large bruise at the injection site.   Patient stated the site was swollen initially then turn bruised and has been healing since.
Achiness; 102 fever; chills.; This is a spontaneous report from a contactable consumer or other non hcp. A 44-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 10Feb2021 05:00 as 1ST DOSE, SINGLE DOSE, dose 2 via an unspecified route of administration on 06Mar2021 01:00 (Batch/Lot number was not reported) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included hypothyroidism. Concomitant medication included levothyroxine (LEVOTHYROXINE). The patient experienced achiness, 102 fever and chills on 05Mar2021 09:30. The patient underwent lab tests and procedures which included body temperature: 102 on. Outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Bruised injection site and very sore for 2 days; fatigue; headache; body aches; very weak
Delayed menstruation for 2 weeks, then extreme menstrual flow for 2 weeks
Redness and warmth noted by parent. Cellulitis diagnosed and treated with Keflex ( left deltoid)
Information has been received from a nurse concerning a 16 year old white female who on 09-JAN-2007, 6-Apr-2007 and 23-Jul-2007 was vaccinated intramuscularly in the left arm with the 1st (lot #654702/0011U), 2nd (lot #657006/0188U) and 3rd (658100/0525U) dose of Gardasil respectively.  On 29-Nov-2007 the patient reported left submandibular superior anterior cervical node swelling for the last 2-3 months.  Nodes enlarge and subside within hours.  The symptoms started in September 2007 (exact date not reported).  The patient received unspecified medical attention.  A rapid strep test was performed, results were negative.  A chemistry panel was run, results were within normal limits with exception to MCHC - high, Eosinophils, Absolute - low, Bun/Creatinine ratio - high.  The patient's outcome was not reported.  No additional information is expected.
patient received a dose of Moderna that had expired the day before; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received a dose of Moderna that had expired the day before) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A, 023M20A and 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received a dose of Moderna that had expired the day before). On 20-Sep-2021, EXPIRED PRODUCT ADMINISTERED (patient received a dose of Moderna that had expired the day before) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that dose was administered around 1 pm on 20 Sep 2021. Vial was punctured around 11 am and the vial's expiration date  was 19 Sep 2021.   No list of Concomitant medications were provided.  No Treatment medications were reported.
shortness of breath; palpitations/rapid heartbeat; liver pain,4 weekspain in the li; severe pain in the lymph nodes under the arms; hip pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), PALPITATIONS (palpitations/rapid heartbeat), HEPATIC PAIN (liver pain,4 weekspain in the li), LYMPH NODE PAIN (severe pain in the lymph nodes under the arms) and ARTHRALGIA (hip pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath) (seriousness criterion medically significant), PALPITATIONS (palpitations/rapid heartbeat) (seriousness criterion medically significant), HEPATIC PAIN (liver pain,4 weekspain in the li) (seriousness criterion medically significant), LYMPH NODE PAIN (severe pain in the lymph nodes under the arms) (seriousness criterion medically significant) and ARTHRALGIA (hip pain) (seriousness criterion medically significant). At the time of the report, DYSPNOEA (shortness of breath), PALPITATIONS (palpitations/rapid heartbeat), HEPATIC PAIN (liver pain,4 weekspain in the li), LYMPH NODE PAIN (severe pain in the lymph nodes under the arms) and ARTHRALGIA (hip pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       After first dose the patient had severe pain in the lymph nodes under the arms liver pain hip pain shortness of breath and palpitations, rapid heartbeat. The concomitant medications on use were not provided. No laboratory data was provided. No treatment information was provided. This case concerns a patient of unknown age and gender with serious unexpected events of dyspnea, palpitations, hepatic pain, lymph node pain, and arthralgia. Event onset with unknown latency after first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns a patient of unknown age and gender with serious unexpected events of dyspnea, palpitations, hepatic pain, lymph node pain, and arthralgia. Event onset with unknown latency after first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Site: Swelling at Injection Site-Mild, Systemic: Hematoma (2.5 cm) at injection site-Mild
ErythemaMultiform, UrticariaPruritus, also swollen lymph nodes, tightness, painful, tender to touch and some movement on injection site armpit Narrative:  5 days post vaccination swollen lymph nodes on injection site armpit. tightness, painful, tender to touch and some movement on injection site armpit. No treatment used. Erythema and itchiness at injection site as well. Hydrocortisone 1% PRN applied to area.
No further adverse effect reported; on 19-FEB-2020 patient received a dose of improperly stored ROTATEQ; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not reported.       On 19-FEB-2020, the patient was vaccinated with a dose of improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) administered orally (strength and dosage regimen were not reported; lot number S014947 has been verified to be valid, expiration date reported and validated as 10-DEC-2020) as prophylaxis (product storage error). No further adverse effect reported.  The temperature excursion was reported as: below 36 degrees Fahrenheit (34 degrees Fahrenheit) for 27 minutes. No previous temperature excursions reported.  A data logger was used.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2002USA009991: US-009507513-2002USA010017: US-009507513-2002USA010018: US-009507513-2002USA010021: US-009507513-2002USA010023: US-009507513-2002USA010046: US-009507513-2002USA010054: US-009507513-2002USA010078: US-009507513-2002USA010083: US-009507513-2002USA010140: US-009507513-2002USA010152: US-009507513-2002USA010216:
Nausea and vomiting  x3 days  Body Aches Fever (low grade) Diarrhea x3 days
The morning after receiving my fifth dose of the The Moderna vaccine, I felt nauseous. A little while after that my stomach was hurting so badly. It was churning, cramping and in knots. I was unable to go to work on Monday because of how I was feeling. I attempted work on Tuesday and only lasted a brief part of the day. I wasn't even able to drive myself home. I saw a Nurse Practitioner on Wednesday and he thought that it could be related to the vaccine, but wanted to rule out other possibilities. I was prescribed Dicyclomine and I was told that I could take some Pepcid.
Information has been received from a physician concerning a 6 month old male, that was born with a fractured left clavicle because he was big at birth, and who had no other history other than sniffles, who was vaccinated with a first, second, and third 2 ml oral dose of rotavirus reassortant vaccine live (human-bovine) on 02-Jul-2007 (Lot# 656845/0409U), 05-Sep-2007 (Lot# 656845/0409U), and 14-Nov-2007 (Lot# 657665/1460U), respectively.  Concomitant therapy included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid, Hib conj vaccine (OMPC) (manufacturer unknown), pneumococcal conj vaccine (unspecified) and influenza virus vaccine (unspecified).  "Eleven days later," on 25-Nov-2007 the patient was throwing up what looked like the color of coffee granules and continued to throw up.  The patient's mother called the physician.  On 26-Nov-2007 the patient's mother took the patient to the hospital and was hospitalized.  At the time the patient was experiencing vomiting and had on loose stool.  It was noted that all kinds of tests were performed.  Blood work showed a high white blood count.  The patient was put on IV fluids and was dehydrated.  The patient had an x-ray of the intestine and an ultrasound.  On 28-Nov-2007, at 9:00 a.m., the patient was rushed to a second hospital and was diagnosed with intussusception.  It was noted that all types of tests were performed, and finally a jelly-like mucuos blood stool was expelled.  The patient's mother stated that seven barium enema procedures were performed on the patient, and the last one worked.  There was no surgery.  The patient was discharged from the hospital on 30-Nov-2007 at 12:00 p.m.  The patient's mother indicated that she was nursing the child and he seemed okay, but later started bucking and thrashing like he was in pain.  The patient's mother took the patient back to the hospital and they observed him for several hours and then he was released, not hospitalized.  The patient's mother indicated that the child was recovering but was still somewhat traumatized by all the events and was weak and clinging.  The physician did not think that the patient's intussusception was realted to rotavirus reassortant vaccine live (human-bovine).  No product quality complaint was involved.  No other information was provided.  The patient's intussusception was considered to be an other important medical event.  Additional information has been requested. 1/16/08-records received for DOS 11/28-11/29/07 and 11/29-11/30/07-DC DX: Intussusception. Successful reduction by barium enema. Returned the same evening for C/O crying and vomiting. Observed and discharged. illness began 3 days prior to admission with vomiting, fussy, resless and crying out in sleep. Low grade fever. Emesis became dark brown and guaiac positive. Passed blood mucousy stool.
7 hours after flu shot, passed out/fell 2 times/chills for about 1 1/2 to 2 hours then gone.
Received vaccine on Friday 12/10/21 at 31 weeks pregnant. On 12/13/21 at 31 weeks and 3 days pregnant woke up to vaginal bleeding around 20 CC?s. No prior history of vaginal bleeding in pregnancy. No new medications were started.
Initially C/O (B) arm pain, nausea, and fatigue at 4pm. Next AM at 8am developed increased somnolence, decreased responsiveness, difficulty responding to questions, and disorientation.
22 patients vaccinated using old vial from 03/8/21; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (22 patients vaccinated using old vial from 03/8/21) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (22 patients vaccinated using old vial from 03/8/21). On 09-Mar-2021, EXPIRED PRODUCT ADMINISTERED (22 patients vaccinated using old vial from 03/8/21) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided by the report. No treatment medication were provided by the reporter.   This case was linked to MOD-2021-208074, MOD-2021-258552, MOD-2021-258572, MOD-2021-258587, MOD-2021-258599, MOD-2021-258615, MOD-2021-258644, MOD-2021-258660, MOD-2021-258672, MOD-2021-258682, MOD-2021-258689, MOD-2021-258691, MOD-2021-258693, MOD-2021-258697, MOD-2021-258699, MOD-2021-258700, MOD-2021-258702, MOD-2021-258703, MOD-2021-258704, MOD-2021-258706, MOD-2021-207548 (Patient Link).
50mm diameter lesion, with tenderness and erythema, noted after shots given and getting larger.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 25-APR-2016, the patient was vaccinated with an expired dose of GARDASIL injection, lot # J009243, expiration date 23-APR-2016 (dose and route were not reported). Concomitant therapies were not provided. No adverse effect was reported. No product quality complain (PQC) was involved. This is one of two reports received from the same reporter. Additional information has been requested.
patient felt dizzy when walking out car. brought pt back inside, gave him cool water, candy & pedisure and layed him down took blood pressure patient layed in supine position for 30min until blood pressure was back up & feeling better. Patient was able to get up and walk around before leaving office
full body rash mostly on trunk. pruritic in nature. no other identified causes. improving currently. 2 weeks of steroids and benadryl has helped.
lymph nodes of the collar bone area and armpit inflamed; Swollen lymph nodes; This is a spontaneous report from a contactable consumer. A 56-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), dose 2 via an unspecified route of administration, administered in Arm Right on 30Mar2021 as a single dose for covid-19 immunization. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication(s) included atorvastatin calcium; sitagliptin phosphate (JANUVIA [SITAGLIPTIN PHOSPHATE]); glipizide. On 31Mar2021, she was in the Emergency Room after getting some side effects due to the Pfizer covid vaccine. She mentions that she got the first dose on 09Mar and the second 30Mar and within 20 h of receiving the second dose she got the lymph nodes of the collar bone area and armpit inflamed and swollen lymph nodes. Therapeutic measures were taken as a result of lymph nodes of the collar bone area and armpit inflamed (lymphadenitis), swollen lymph nodes (lymphadenopathy) with some Advil yesterday and on night on 31Mar2021 and some Tylenol. Outcome of the event was not recovered. No follow up attempts are possible. No further information is expected.
Initial unsolicited report received from a consumer (patient) on 06 September 2016. This case involves a 67-year-old female patient who was vaccinated with a second dose of IFLUZONE HD (batch number, expiry date, site of administrated was not reported) intramuscularly on 2015. It was reported that, the patient was allergic to formaldehyde and balsam of teru. Medical history of patient revealed that she was multiple allergists (unspecified). Illness at time of vaccination and any other vaccinations within 4 weeks of vaccinations was reported as none. On an unspecified date, following the vaccination, the patient had experienced red raised bumps on hands to her elbows (lasted almost a year), arms were purplish in color and pain at the injection site (resolved). Patient also received Fluzone HD previously on an unspecified date in 2014, after which patient experienced red raised bumps on hands to her elbows (lasted almost a year), arms were purplish in color and pain at the injection site (resolved). Patient required ER or doctor visit. Lab data includes multiple allergy tests including biopsy and scrapings. Corrective treatment was received for rash (unspecified) (reported as no treatments worked to resolve the rash). The patient was recovered from the events. Also reported as rash was almost gone. List of documents held by sender: none.
This spontaneous report was received from a pharmacist and refers to a 26 year old patient of unknown gender. The patient's pertinent medical history and concurrent conditions were not reported. Concomitant therapies included sterile diluent (MERCK STERILE DILUENT). On 28-NOV-2017, the patient was vaccinated with an expired VARIVAX lot # L042265 with expiration date 26-OCT-2017 (dosage and route were not reported). No adverse effects reported.
The patient and his parent were due for second doses on 5/6/2021. On 5/6/2021, parents called us and informed us that patient would not be coming to his second dose appointment d/t very bad side effects from the first one. Parent took a printout of patient's symptoms when she came in for her second dose. Symptoms started  24 hours after vaccine. Symptoms were as follows: extreme stiffness/soreness/pain in entire neck, feeling of being strangled, shortness of breath, trouble swallowing, acute weakness and fatigue, cannot hold head up, feeling of falling forward, base and top of spinal cord pain and numbness, shooting pains and numbness in head and neck, loss of appetite, weakness and very minor pains in both arms, dizziness, brain fog. Symptoms described as "extreme" for 3 weeks. Patient reports tat the first week was "very, very bad." Pt reports that most symptoms still come and go even after one full month. The neck and base of spine are still the most afflicted at this point in time and fatigue is ongoing. According to the patient's parent, no medical care was sought. Recommended patient should see a doctor.
Red, swollen, stabbing pain. I received the Influenza Virus Vaccine (AFLURIA preservative free intramuscular suspension prefilled syringe 0.5 ML). I have this large red spot or rash on my arm (picture took). It has been swollen and hurting with a stabbing pain where the needle went in. I have always taken the flu shot this is the first time I have ever had any problems. Have been sleeping most of the day. Thinking things may get better. Since, I have never had any problems before in the past. If, the problem don't get any better I will be going to the hospital to seek help.
patient seen in clinic 5/26 for severe head ache, chest pain, diaphoresis, subjective fever and chills, SOB.  Transferred to ER elevated troponin, transferred to other Hospital where he underwent cardiac cath and diagnosed with NSTEMI.
Site: Redness at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Chills-Mild, Additional Details: Patient recieved the vaccine on 11/6/22 and started having symptoms on 11/7/22. Pt noted that she can still cover the entirety of the rash on her left arm with her hand. it was instructed to have the pt take benadryl